Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:49:06 UTC |
---|
HMDB ID | HMDB0000879 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Tetrahydrodeoxycorticosterone |
---|
Description | The neurosteroid allotetrahydrodeoxycorticosterone (THDOC) is an allosteric modulator of the GABA(A) receptor. Although the role of THDOC within the brain is undefined, recent studies indicate that stress induces THDOC to levels that can activate GABA(A) receptors. These results might have significant implications for human stress-sensitive conditions such as epilepsy, post-traumatic stress disorder and depression. (PMID 12628349 ). |
---|
Structure | [H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)CC[C@]12C InChI=1S/C21H34O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h13-18,22-23H,3-12H2,1-2H3/t13-,14+,15-,16-,17-,18+,20-,21-/m0/s1 |
---|
Synonyms | Value | Source |
---|
5alpha-THDOC | Kegg | 3alpha,21-Dihydroxy-5alpha-pregnan-20-one | Kegg | 5a-THDOC | Generator | 5Α-thdoc | Generator | 3a,21-Dihydroxy-5a-pregnan-20-one | Generator | 3Α,21-dihydroxy-5α-pregnan-20-one | Generator | 3alpha,21-Dihydroxy-5beta-pregnan-20-one | HMDB | 5-alpha-THDOC | HMDB | Allotetrahydrodeoxycorticosterone | HMDB | Deoxycorticosterone-21-aminopropane | HMDB | Tetrahydro-11-deoxycorticosterone | HMDB | 3 alpha,21-Dihydroxy-5 beta-pregnan-20-one | HMDB | 3 alpha,5 beta-Tetrahydrodeoxycorticosterone | HMDB | 3 beta,5 alpha-Tetrahydrodeoxycorticosterone | HMDB | 3,21-Dihydroxypregnan-20-one | HMDB | 5alpha-Pregnan-3alpha,21-diol-20-one | HMDB | 5alpha-Pregnane-3alpha,21-diol-20-one | HMDB | THDOC | HMDB | Pregnane-3,21-diol-20-one | HMDB | Tetrahydrodeoxycorticosterone, (3alpha,5alpha)-isomer | HMDB | Tetrahydrodeoxycorticosterone, (3beta,5alpha)-isomer | HMDB | Tetrahydrodesoxycorticosterone | HMDB |
| Show more...
---|
Chemical Formula | C21H34O3 |
---|
Average Molecular Weight | 334.4929 |
---|
Monoisotopic Molecular Weight | 334.250794954 |
---|
IUPAC Name | 2-hydroxy-1-[(1S,2S,5R,7S,10R,11S,14S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]ethan-1-one |
---|
Traditional Name | tetrahydrodeoxycorticosterone |
---|
CAS Registry Number | 567-03-3 |
---|
SMILES | [H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C21H34O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h13-18,22-23H,3-12H2,1-2H3/t13-,14+,15-,16-,17-,18+,20-,21-/m0/s1 |
---|
InChI Key | CYKYBWRSLLXBOW-GDYGHMJCSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Hydroxysteroids |
---|
Direct Parent | 21-hydroxysteroids |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 21-hydroxysteroid
- Pregnane-skeleton
- 20-oxosteroid
- 3-hydroxysteroid
- 3-alpha-hydroxysteroid
- Oxosteroid
- Alpha-hydroxy ketone
- Cyclic alcohol
- Secondary alcohol
- Ketone
- Organic oxygen compound
- Organooxygen compound
- Primary alcohol
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Tetrahydrodeoxycorticosterone,1TMS,isomer #1 | C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)CO[Si](C)(C)C)CC[C@@H]12 | 2985.0 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,1TMS,isomer #2 | C[C@]12CC[C@@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)CO)CC[C@@H]12 | 3006.1 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,1TMS,isomer #3 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=C(CO)O[Si](C)(C)C | 2937.3 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,1TMS,isomer #4 | C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=CO)O[Si](C)(C)C)CC[C@@H]12 | 2941.8 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TMS,isomer #1 | C[C@]12CC[C@@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)CO[Si](C)(C)C)CC[C@@H]12 | 2990.1 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TMS,isomer #2 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=C(CO[Si](C)(C)C)O[Si](C)(C)C | 3012.0 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TMS,isomer #3 | C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3003.2 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TMS,isomer #4 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=C(CO)O[Si](C)(C)C | 2983.7 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TMS,isomer #5 | C[C@]12CC[C@@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=CO)O[Si](C)(C)C)CC[C@@H]12 | 2952.0 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=C(CO[Si](C)(C)C)O[Si](C)(C)C | 3033.1 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=C(CO[Si](C)(C)C)O[Si](C)(C)C | 3053.8 | Standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TMS,isomer #1 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O[Si](C)(C)C)CC[C@@]43C)[C@@H]1CCC2=C(CO[Si](C)(C)C)O[Si](C)(C)C | 3362.5 | Standard polar | 33892256 | Tetrahydrodeoxycorticosterone,3TMS,isomer #2 | C[C@]12CC[C@@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3014.5 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TMS,isomer #2 | C[C@]12CC[C@@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 2969.3 | Standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TMS,isomer #2 | C[C@]12CC[C@@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=CO[Si](C)(C)C)O[Si](C)(C)C)CC[C@@H]12 | 3384.8 | Standard polar | 33892256 | Tetrahydrodeoxycorticosterone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 3283.3 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)CO)CC[C@@H]32)C1 | 3249.6 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(CO)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 3232.9 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,1TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC(=CO)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 3195.3 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3528.4 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 3565.0 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C | 3490.9 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC(CO)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3517.4 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)OC(=CO)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3450.3 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3805.9 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3724.8 | Standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(O[Si](C)(C)C(C)(C)C)=C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3654.6 | Standard polar | 33892256 | Tetrahydrodeoxycorticosterone,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3753.2 | Semi standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3600.0 | Standard non polar | 33892256 | Tetrahydrodeoxycorticosterone,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O[Si](C)(C)C(C)(C)C)CC[C@]4(C)[C@H]3CC[C@]12C | 3662.7 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-05r0-0196000000-64a1fd698ec4c3241ddd | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (2 TMS) - 70eV, Positive | splash10-03di-1110900000-7b3fa2dd630d949e0a05 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tetrahydrodeoxycorticosterone GC-MS (TBDMS_2_5) - 70eV, Positive | Not Available | 2021-11-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 10V, Positive-QTOF | splash10-014r-0039000000-fbe3bc4f80d70022eede | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 20V, Positive-QTOF | splash10-014s-0196000000-a18bb17686131ac405ed | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 40V, Positive-QTOF | splash10-0a4j-1191000000-3c4df4d65182d58267d4 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 10V, Negative-QTOF | splash10-001i-0009000000-cfaa8c0de99a027f7eb7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 20V, Negative-QTOF | splash10-0kur-2049000000-5582f42ba1bd76b52de1 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 40V, Negative-QTOF | splash10-0a4i-4092000000-3511eadb036a8910b388 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 10V, Negative-QTOF | splash10-001i-0009000000-3b9bbceb7e7c6cb37f9a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 20V, Negative-QTOF | splash10-0f89-0019000000-f0001403bdba14e2bf6c | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 40V, Negative-QTOF | splash10-0f89-0089000000-91f07645e31574724cf2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 10V, Positive-QTOF | splash10-000i-0019000000-c5d82d2f86c8ce78130a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 20V, Positive-QTOF | splash10-014s-0955000000-8d4884a7a7fed4ace8d8 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tetrahydrodeoxycorticosterone 40V, Positive-QTOF | splash10-052b-4930000000-4187c9aebfbeff89d19e | 2021-09-22 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.0052 +/- 0.0010 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.013 (0.011-0.015) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.026 +/- 0.019 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.0056 +/- 0.0023 uM | Adult (>18 years old) | Both | Psychiatric disorder | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Inflammatory bowel disease | | details | Urine | Detected and Quantified | 0.045 (0.027-0.062) umol/mmol creatinine | Adult (>18 years old) | Both | Deficiency in the 11 beta-hydroxylation of corticosteroids | | details | Urine | Detected and Quantified | 0.0079 +/- 0.0056 umol/mmol creatinine | Adult (>18 years old) | Female | Thyroid cancer | | details | Urine | Detected and Quantified | 0.000299 umol/mmol creatinine | Infant (0-1 year old) | Female | Lipoid Adrenal Hyperplasia | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Alcoholism |
---|
- Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR: Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):309-14. Epub 2006 Sep 7. [PubMed:16959481 ]
| Major depressive disorder |
---|
- Nieminen LR, Makino KK, Mehta N, Virkkunen M, Kim HY, Hibbeln JR: Relationship between omega-3 fatty acids and plasma neuroactive steroids in alcoholism, depression and controls. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):309-14. Epub 2006 Sep 7. [PubMed:16959481 ]
| Inflammatory bowel disease |
---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
| Thyroid cancer |
---|
- Kim KM, Jung BH, Lho DS, Chung WY, Paeng KJ, Chung BC: Alteration of urinary profiles of endogenous steroids and polyunsaturated fatty acids in thyroid cancer. Cancer Lett. 2003 Dec 30;202(2):173-9. [PubMed:14643447 ]
| Lipoid Congenital Adrenal Hyperplasia |
---|
- Hauffa BP, Miller WL, Grumbach MM, Conte FA, Kaplan SL: Congenital adrenal hyperplasia due to deficient cholesterol side-chain cleavage activity (20, 22-desmolase) in a patient treated for 18 years. Clin Endocrinol (Oxf). 1985 Nov;23(5):481-93. [PubMed:3841304 ]
|
|
---|
Associated OMIM IDs | - 608516 (Major depressive disorder)
- 201710 (Lipoid Congenital Adrenal Hyperplasia)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022296 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 91953 |
---|
KEGG Compound ID | C13713 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Tetrahydrodeoxycorticosterone |
---|
METLIN ID | 5840 |
---|
PubChem Compound | 101771 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 805752 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | CE5072 |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Holland, Herbert L.; Ninniss, Ronald W.; Brown, Frances M. Stereochemistry of hydrogen loss during C-21 dehydroxylation of tetrahydrodeoxycorticosterone by Eubacterium lentum. Canadian Journal of Chemistry (1989), 67(10), 1590-5. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Ohse M, Matsuo M, Ishida A, Kuhara T: Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine. J Mass Spectrom. 2002 Sep;37(9):954-62. [PubMed:12271438 ]
- Van Kuilenburg AB, Van Lenthe H, Assmann B, Gohlich-Ratmann G, Hoffmann GF, Brautigam C, Wevers RA, Van Gennip AH: Detection of beta-ureidopropionase deficiency with HPLC-electrospray tandem mass spectrometry and confirmation of the defect at the enzyme level. J Inherit Metab Dis. 2001 Dec;24(7):725-32. [PubMed:11804209 ]
- Raven PW, O'Dwyer AM, Taylor NF, Checkley SA: The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles. Psychoneuroendocrinology. 1996 Apr;21(3):277-86. [PubMed:8817726 ]
- Schneider MA, Honour JW: Adrenal cortex, tumor, and peripheral production of deoxycorticosterone. Steroids. 1992 Jan;57(1):7-12. [PubMed:1316648 ]
- de Lange WE, Doorenbos H: Incomplete virilization and subclinical mineralocorticoid excess in a boy with partial 17,20-desmolase/17 alpha-hydroxylase deficiency. Acta Endocrinol (Copenh). 1990 Feb;122(2):263-6. [PubMed:2156398 ]
- Koepp P, Vollmin JA, Zachmann M, Curtius HC: Determination of urinary tetrahydro-11-deoxycortisol and tetrahydro-11-deoxycorticosterone by gas chromatography. Acta Endocrinol (Copenh). 1971 Apr;66(4):756-68. [PubMed:5108103 ]
- Stahl M, Kapp JP, Zachmann M, Girard J: Effect of a single oral dose of metyrapone on secretion of growth hormone and urinary tetrahydro-11-deoxycortisol and tetrahydro-11-deoxycorticosterone excretion in children. Helv Paediatr Acta. 1972 Jun;27(2):147-53. [PubMed:4644861 ]
- Reddy DS: Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol Sci. 2003 Mar;24(3):103-6. [PubMed:12628349 ]
|
---|